5.675
price up icon2.25%   0.125
after-market アフターアワーズ: 5.67 -0.005 -0.09%
loading
前日終値:
$5.55
開ける:
$5.55
24時間の取引高:
557.92K
Relative Volume:
0.68
時価総額:
$392.44M
収益:
$46.02M
当期純損益:
$-70.80M
株価収益率:
-3.1181
EPS:
-1.82
ネットキャッシュフロー:
$-1.61M
1週間 パフォーマンス:
+18.23%
1か月 パフォーマンス:
-14.40%
6か月 パフォーマンス:
-49.10%
1年 パフォーマンス:
-72.90%
1日の値動き範囲:
Value
$5.37
$5.74
1週間の範囲:
Value
$4.70
$5.86
52週間の値動き範囲:
Value
$3.91
$21.25

Eyepoint Pharmaceuticals Inc Stock (EYPT) Company Profile

Name
名前
Eyepoint Pharmaceuticals Inc
Name
セクター
Healthcare (1151)
Name
電話
617-926-5000
Name
住所
480 PLEASANT STREET, WATERTOWN, MA
Name
職員
144
Name
Twitter
@eyepointpharma
Name
次回の収益日
2025-03-05
Name
最新のSEC提出書
Name
EYPT's Discussions on Twitter

EYPT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
EYPT
Eyepoint Pharmaceuticals Inc
5.675 392.44M 46.02M -70.80M -1.61M -1.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.10 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.16 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
596.20 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
234.56 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
230.98 26.16B 3.81B -644.79M -669.77M -6.24

Eyepoint Pharmaceuticals Inc Stock (EYPT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-07 開始されました Citigroup Buy
2024-10-16 開始されました Scotiabank Sector Outperform
2024-08-28 開始されました Jefferies Buy
2024-01-22 開始されました JP Morgan Overweight
2023-11-02 開始されました Mizuho Buy
2023-04-21 開始されました Robert W. Baird Outperform
2022-07-07 開始されました Chardan Capital Markets Buy
2021-03-01 開始されました Cowen Outperform
2021-01-28 開始されました Cantor Fitzgerald Overweight
2020-04-06 ダウングレード B. Riley FBR Buy → Neutral
2019-11-04 再開されました Laidlaw Buy
2019-09-12 開始されました Guggenheim Buy
すべてを表示

Eyepoint Pharmaceuticals Inc (EYPT) 最新ニュース

pulisher
Apr 16, 2025

Pars Planitis Market Set to Grow Substantially Through 2032, - openPR.com

Apr 16, 2025
pulisher
Apr 16, 2025

EyePoint (EYPT) Offers Stock Options as Inducement for New Hires | EYPT Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | EYPT Stock News - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Eyepoint Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 16, 2025
pulisher
Apr 16, 2025

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Apr 16, 2025
pulisher
Apr 16, 2025

EyePoint Expands Team with Strategic Stock Options Package Worth $370K - Stock Titan

Apr 16, 2025
pulisher
Apr 16, 2025

How the (EYPT) price action is used to our Advantage - news.stocktradersdaily.com

Apr 16, 2025
pulisher
Apr 09, 2025

Nano Silicon Drug Delivery Platform Market to Witness Massive - openPR.com

Apr 09, 2025
pulisher
Apr 06, 2025

Ex-Dividend Date Nearing for These 10 Stocks – Week of April 7, 2025 - The Globe and Mail

Apr 06, 2025
pulisher
Apr 05, 2025

EyePoint Pharmaceuticals' US$84m Market Cap Fall Books Insider Losses - simplywall.st

Apr 05, 2025
pulisher
Apr 04, 2025

EyePoint Pharmaceuticals at RBC Conference: Insights on Duravu’s Promise By Investing.com - Investing.com Canada

Apr 04, 2025
pulisher
Apr 03, 2025

Working At Eyepoint - EyePoint Pharmaceuticals

Apr 03, 2025
pulisher
Apr 02, 2025

Here's Why We're Watching EyePoint Pharmaceuticals' (NASDAQ:EYPT) Cash Burn Situation - Yahoo Finance

Apr 02, 2025
pulisher
Mar 30, 2025

Long Term Trading Analysis for (EYPT) - news.stocktradersdaily.com

Mar 30, 2025
pulisher
Mar 28, 2025

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Recommendation of “Buy” from Analysts - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference - The Manila Times

Mar 27, 2025
pulisher
Mar 27, 2025

EyePoint's CEO Takes Center Stage: Key Updates Coming at RBC Ophthalmology Conference - Stock Titan

Mar 27, 2025
pulisher
Mar 27, 2025

EYPTEyepoint Pharmac Latest Stock News & Market Updates - Stock Titan

Mar 27, 2025
pulisher
Mar 27, 2025

What is Chardan Capital’s Estimate for EYPT FY2026 Earnings? - Defense World

Mar 27, 2025
pulisher
Mar 23, 2025

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Shares Bought by Bank of New York Mellon Corp - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

3 US Healthcare Stocks That Might Be Undervalued 2025 - Value The Markets

Mar 21, 2025
pulisher
Mar 20, 2025

(EYPT) Investment Report - news.stocktradersdaily.com

Mar 20, 2025
pulisher
Mar 19, 2025

Mizuho maintains EyePoint stock Outperform with $30 target By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Mizuho maintains EyePoint stock Outperform with $30 target - Investing.com India

Mar 18, 2025
pulisher
Mar 14, 2025

Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga India

Mar 14, 2025
pulisher
Mar 14, 2025

StockNews.com Upgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) to “Sell” - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

EyePoint Pharmaceuticals at Leerink’s Conference: DuraView’s Promising Potential By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 10, 2025

Q1 EPS Estimate for EyePoint Pharmaceuticals Cut by Analyst - Defense World

Mar 10, 2025
pulisher
Mar 10, 2025

Research Analysts Set Expectations for EYPT FY2025 Earnings - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

EyePoint Pharmaceuticals Inc (EYPT) Reports Q3 2023 Financial Re - GuruFocus.com

Mar 09, 2025
pulisher
Mar 09, 2025

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Full-Year Results: Here's What Analysts Are Forecasting For This Year - simplywall.st

Mar 09, 2025
pulisher
Mar 08, 2025

Rhumbline Advisers Purchases 12,443 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Chardan Capital Reiterates “Buy” Rating for EyePoint Pharmaceuticals (NASDAQ:EYPT) - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

HC Wainwright Reaffirms Buy Rating for EyePoint Pharmaceuticals (NASDAQ:EYPT) - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

Demystifying EyePoint Pharmaceuticals: Insights From 4 Analyst Reviews - Benzinga

Mar 06, 2025
pulisher
Mar 06, 2025

EyePoint Pharmaceuticals: Promising Clinical Progress and Strong Financial Position Justify Buy Rating - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

H.C. Wainwright maintains EyePoint stock Buy rating, $22 target - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

H.C. Wainwright maintains EyePoint stock Buy rating, $22 target By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 06, 2025
pulisher
Mar 06, 2025

Despite Recent Gains, EyePoint Pharmaceuticals Insiders Are Still Down US$32k - Yahoo Finance

Mar 06, 2025
pulisher
Mar 06, 2025

EyePoint Pharmaceuticals: Q4 Earnings Snapshot - Midland Daily News

Mar 06, 2025
pulisher
Mar 06, 2025

EyePoint Pharmaceuticals Inc (EYPT) Q4 2024 Earnings Call Highli - GuruFocus.com

Mar 06, 2025
pulisher
Mar 06, 2025

EyePoint Pharmaceuticals Inc (EYPT) Q4 2024 Earnings Call Highlights: Navigating Challenges ... - Yahoo Finance

Mar 06, 2025
pulisher
Mar 06, 2025

EyePoint Pharmaceuticals Inc (EYPT) Q4 2024 Earnings Call Highlights: Navigating Challenges ... By GuruFocus - Investing.com Canada

Mar 06, 2025
pulisher
Mar 05, 2025

EyePoint Pharmaceuticals Reports 2024 Financial Results - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

EyePoint Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 05, 2025
pulisher
Mar 05, 2025

EyePoint Pharmaceuticals (EYPT) Reports Q4 Earnings: What Key Metrics Have to Say - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

Earnings call transcript: EyePoint Pharmaceuticals Q4 2024 results show revenue beat, EPS miss - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Earnings call transcript: EyePoint Pharmaceuticals Q4 2024 results show revenue beat, EPS miss By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 05, 2025
pulisher
Mar 05, 2025

EyePoint Pharmaceuticals Q4 2024 Earnings: Revenue Beats at $11. - GuruFocus.com

Mar 05, 2025

Eyepoint Pharmaceuticals Inc (EYPT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.04
price up icon 2.51%
$72.65
price up icon 3.49%
$32.60
price up icon 1.27%
$24.61
price up icon 6.77%
$98.76
price up icon 0.52%
biotechnology ONC
$230.98
price up icon 1.24%
大文字化:     |  ボリューム (24 時間):